Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Ibex Technologies presents data on heparin neutralization agent

May 21, 1997

Selective thrombin inhibitors revealed by HMR

May 21, 1997

Searle describes antiplatelet agents

May 20, 1997

3-D describes potent and selective thrombin inhibitors

May 15, 1997

Factor Xa inhibitors from 3-D

May 15, 1997

Fibrinogen antagonists reported by Lilly/Cor Therapeutics

May 14, 1997

RPR receives FDA clearance for new indication of enoxaparin

May 13, 1997

Serine protease inhibitors described by 3-D

May 12, 1997

BMS and Sanofi seek U.S. and European approval for clopidogrel

May 8, 1997

Genentech plans phase III studies of second-generation t-PA

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...